AnalystsAndres Maldonado
Andres Maldonado's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 11%
#556 out of 5177 analysts
Average Return
+20.21%
Win Rate
42%39 out of 92
Risk vs Reward
Poor
Good

Andres Maldonado's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Erasca IncERAS
+554.79%$1.46$9.56
2025-04-30 -
2026-01-15
Buy
Erasca IncERAS
+524.84%$1.53$9.56
2025-03-21 -
2026-01-15
Buy
Scholar Rock Holding CorpSRRK
+314.00%$8.07$33.41
2024-06-25 -
2025-06-24
Buy
Scholar Rock Holding CorpSRRK
+228.91%$8.06$26.51
2023-10-12 -
2024-10-11
Buy
Scholar Rock Holding CorpSRRK
+215.71%$9.80$30.94
2024-06-04 -
2025-06-03
Buy

Andres Maldonado Analyst Color

Get additional color on Andres Maldonado's coverage of popular stocks

Andres Maldonado's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Novabridge BiosciencesNBP
1Buy$7.00+91.26%Reiterates
6 months ago
Aura Biosciences IncAURA
1Buy$22.00+330.53%Assumes
8 months ago
Zentalis Pharmaceuticals IncZNTL
1Buy$10.00+216.46%Reiterates
8 months ago
Corbus Pharmaceuticals Holdings IncCRBP
2Buy$40.00+389.60%Maintains
8 months ago
Tscan Therapeutics IncTCRX
1Buy$10.00+777.19%Maintains
8 months ago
Erasca IncERAS
10Buy$6.00-37.24%Reiterates
9 months ago
Foghorn Therapeutics IncFHTX
1Buy$13.00+107.01%Reiterates
9 months ago
Sutro Biopharma IncSTRO
1Hold$20.00+53.02%Reiterates
9 months ago
Protara Therapeutics IncTARA
1Buy$23.00+356.35%Reiterates
9 months ago
Cg Oncology IncCGON
13Buy$75.00+41.32%Reiterates
9 months ago
Day One Biopharmaceuticals IncDAWN
14Buy$36.00+242.86%Reiterates
9 months ago
Mural Oncology PLCMURA
5Buy$6.00+194.12%Maintains
10 months ago
Werewolf Therapeutics IncHOWL
16Buy$15.00+2,622.32%Reiterates
10 months ago
Engene Holdings IncENGN
2Buy$25.00+172.27%Reiterates
10 months ago
Scholar Rock Holding CorpSRRK
13Buy$50.00N/AMaintains
a year ago
Imagenebio IncIMA
11Buy$48.00N/AReiterates
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.